Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

narazaciclib (ON 123300)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

HanX Biopharma, Onconova

Drug class:

CDK4 inhibitor, CDK6 inhibitor, ARK5 inhibitor

Related drugs:

MYC overexpression	Hepatocellular Cancer	MYC overexpression	Hepatocellular Cancer	ON 123300 Sensitive: D – Preclinical AACR 2023 - 1 week (New D) ON 123300 Sensitive : D AACR 2023 - 1wk	ON 123300 Sensitive: D – Preclinical AACR 2023 - 1 week ON 123300 Sensitive : D AACR 2023 - 1 week - (New D)
NUAK1 overexpression	Hepatocellular Cancer	NUAK1 overexpression	Hepatocellular Cancer	ON 123300 Sensitive: D – Preclinical AACR 2023 - 1 week (New D) ON 123300 Sensitive : D AACR 2023 - 1wk	ON 123300 Sensitive: D – Preclinical AACR 2023 - 1 week ON 123300 Sensitive : D AACR 2023 - 1 week - (New D)